Methods to decrease postoperative infections following posterior cervical spine surgery

Journal of Bone and Joint Surgery

Volumn 95, Issue 6, 2013, Pages 549-554

  Pahys, Joshua M ^a   Pahys, Jenny R ^a   Cho, Samuel K ^b   Kang, Matthew M ^c   Zebala, Lukas P ^d   Hawasli, Ammar H ^d   Sweet, Fred A ^e   Lee, Dong Ho ^d   Riew, K Daniel ^d  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c REGIONS HOSPITAL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Rockford Spine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTHRODESIS; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FORAMINOTOMY; HUMAN; INFECTION PREVENTION; INFECTION RATE; LAMINECTOMY; LAMINOPLASTY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OSTEOTOMY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SMOKING; SPINE SURGERY; SURGICAL DRAINAGE; AGED; ANTIBIOTIC PROPHYLAXIS; CERVICAL SPINE; CLINICAL PROTOCOL; EVALUATION; INTRAVENOUS ADMINISTRATION; METHODOLOGY; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; RISK; RISK FACTOR; SPINE FUSION; STATISTICAL MODEL; SURGICAL INFECTION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; WOUND DRAINAGE;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; CERVICAL VERTEBRAE; CLINICAL PROTOCOLS; DRAINAGE; FEMALE; HUMANS; LAMINECTOMY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OSTEOTOMY; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL FUSION; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; VANCOMYCIN;

MLCS; MLOWN;

EID: 84877132903     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.00756     Document Type: Article

References (16)

1. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield J, Fraser VJ. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am. 2008 Jan;90(1): 62-9.
2. Olsen MA, Mayfield J, Lauryssen C, Polish LB, Jones M, Vest J, Fraser VJ. Risk factors for surgical site infection in spinal surgery. J Neurosurg. 2003 Mar; 98(2)(Suppl): 149-55.
3. Zeidman SM, Ducker TB, Raycroft J. Trends and complications in cervical spine surgery: 1989-1993. J Spinal Disord. 1997 Dec;10(6): 523-6.
4. Watanabe M, Sakai D, Matsuyama D, Yamamoto Y, Sato M, Mochida J. Risk factors for surgical site infection following spine surgery: efficacy of intraoperative saline irrigation. J Neurosurg Spine. 2010 May;12(5): 540-6.
5. Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011 Nov 15;36(24): 2084-8.
6. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007 Mar-Apr;122(2): 160-6.
7. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007 Oct 17;298(15): 1763-71.
8. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis. 2007 Nov 1;45(9): 1132-40.
9. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, Cohen O, Milo S. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002 Feb;123(2): 326-32.
10. Moise PA, Smyth DS, El-Fawal N, Robinson DA, Holden PN, Forrest A, Sakoulas G. Microbiological effects of prior vancomycin use in patients with methicillinresistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2008 Jan;61(1): 85-90.
11. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006 Apr;27(11): 2450-67.
12. Chilukuri DM, Shah JC. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections. Pharm Res. 2005 Apr;22(4): 563-72.
13. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000 Mar 9;342(10): 710-21.
14. Calderone RR, Garland DE, Capen DA, Oster H. Cost of medical care for postoperative spinal infections. Orthop Clin North Am. 1996 Jan;27(1): 171-82.
15. Sasso RC, Garrido BJ. Postoperative spinal wound infections. J Am Acad Orthop Surg. 2008 Jun;16(6): 330-7.
16. McNamara DR, Steckelberg JM. Vancomycin. J Am Acad Orthop Surg. 2005 Mar-Apr;13(2): 89-92.